Correction for partial volume effects in PET: principle and validation.
about
Morphological and glucose metabolism abnormalities in alcoholic Korsakoff's syndrome: group comparisons and individual analysesMR-less surface-based amyloid assessment based on 11C PiB PETPET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to PathophysiologyRegional variability of imaging biomarkers in autosomal dominant Alzheimer's diseasePET/MRI for neurologic applications.Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET dataFully automated calculation of image-derived input function in simultaneous PET/MRI in a sheep modelNonparametric Residue Analysis of Dynamic PET Data With Application to Cerebral FDG Studies in Normals.Digital reconstruction of the cell body in dense neural circuits using a spherical-coordinated variational modelLongitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallyprideSimultaneous Tumor Segmentation, Image Restoration, and Blur Kernel Estimation in PET Using Multiple RegularizationsA channelized Hotelling observer study of lesion detection in SPECT MAP reconstruction using anatomical priors.Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).Estimation of input functions from dynamic [18F]FLT PET studies of the head and neck with correction for partial volume effects.Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.Analysis of variance in neuroreceptor ligand imaging studies.A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Partial volume correction strategies for quantitative FDG PET in oncology.Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.Influence of the partial volume correction method on (18)F-fluorodeoxyglucose brain kinetic modelling from dynamic PET images reconstructed with resolution model based OSEM.Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's diseaseUsing cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.Brain docosahexaenoic acid [DHA] incorporation and blood flow are increased in chronic alcoholics: a positron emission tomography study corrected for cerebral atrophy.Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatumCross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.When structure affects function--the need for partial volume effect correction in functional and resting state magnetic resonance imaging studies.Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's diseasePreoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.Analysis of three-dimensional aerosol deposition in pharmacologically relevant terms: beyond black or white ROIsFactors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.Partial-volume effect correction in positron emission tomography brain scan image using super-resolution image reconstruction.
P2860
Q21142710-7689E426-3A14-4066-8283-5F2972D6D94EQ24618963-DB12FDD3-6481-4C8B-9E0F-C752DBD77925Q26750798-84A1DEFE-C4A7-4BFD-8A2B-14646558AE6DQ30557788-7195BFC3-32E5-4730-A522-0D2B9D3443DFQ30577115-1D5F161B-FEBC-41DF-BF76-D0DD24EA2D48Q30722226-2B11AFB0-95C6-4167-B556-E9418EBD44F3Q31044820-D157ECF3-46F2-4F43-B4D4-FF4A5C4D3D26Q33510711-B522A17F-0C42-408D-9CA9-4D1BB7F658B0Q33612638-A3AFA0C4-A28F-4C3F-AA6F-A4EC85724234Q33687554-7FB8537B-6902-44AE-B70E-B1657E39D5E4Q33733258-DE8B7730-9654-4F80-BBB7-04547CC2DD53Q33777233-1C849AE1-B6BD-496F-B83E-9642B77C7932Q33815486-0F11D309-B563-477A-96F5-3A262B10D0E7Q33833784-2FE27403-B8E8-4D31-B9EE-1F0326266CD0Q33944002-051D7B93-0AEE-468A-A98C-41FF533C8B14Q33944876-E9F8F472-A5C4-4050-ABE8-37E2C28946E4Q33988394-EF486E73-541E-44C5-8AD5-58535460074DQ33999407-9F3A776A-3C26-472C-8186-7EAE1C219C85Q34017591-A455DE17-1BC8-47C3-AA16-88104C443E1CQ34030711-EA84EF49-1CD8-4A64-A399-3C0BBB2EFDA1Q34054615-4972DAA2-8E66-4BA2-8559-7286C75A3CDEQ34187457-BAD32808-5EBD-4AC0-A916-27442F11E314Q34498348-C0EA93F8-6712-4A56-8A2F-862F251C98FCQ34522650-C6622770-3BD5-46D0-9363-F7A87249566FQ34606321-FBB38722-FECB-44C6-BAF3-6159292F886EQ34671684-19896405-879F-4BD1-AC16-D2652751CC7EQ34689059-953DDCAA-36DE-4DFA-984F-BD7B8EBF7E44Q34712689-E7FECFA6-C922-4EC1-90FE-1F5C0C4A8D41Q35009101-1B4DC510-AFA2-4B77-B862-9C4EA77A60B7Q35010074-F8AECA2A-78FF-4374-8515-7D8FE5363717Q35014986-38D63EFC-7BB1-4965-93B3-EE98A1987B5EQ35112618-2DFFFA8E-EE35-4C87-915D-917BC7D64E20Q35474769-C225AE51-31B4-474C-AB46-6F8454E0D248Q35680233-CC4A4E35-F73D-44EB-A3C2-D9FA7E980DC6Q35794275-7B61909C-56D1-4CD1-9781-9D376104ABBBQ35861064-C174EFFA-9EA9-4EA9-8F15-DF8F6F528101Q35894822-2CE74590-2963-444A-BC13-F7793797CF70Q36070835-5430BEA9-89EA-484A-9601-D3C02DEB2B95Q36175217-AB798735-E282-4FCF-8BE4-E466071B7706Q36187165-65347B51-AB8F-4745-A62F-E0A7C2952F02
P2860
Correction for partial volume effects in PET: principle and validation.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Correction for partial volume effects in PET: principle and validation.
@ast
Correction for partial volume effects in PET: principle and validation.
@en
Correction for partial volume effects in PET: principle and validation.
@nl
type
label
Correction for partial volume effects in PET: principle and validation.
@ast
Correction for partial volume effects in PET: principle and validation.
@en
Correction for partial volume effects in PET: principle and validation.
@nl
prefLabel
Correction for partial volume effects in PET: principle and validation.
@ast
Correction for partial volume effects in PET: principle and validation.
@en
Correction for partial volume effects in PET: principle and validation.
@nl
P1476
Correction for partial volume effects in PET: principle and validation.
@en
P304
P407
P577
1998-05-01T00:00:00Z